Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:53 PM
Ignite Modification Date:
2025-12-24 @ 5:53 PM
NCT ID:
NCT00740168
Eligibility Criteria:
Inclusion Criteria:
* patients who wish and need bevacizumab treatment for underlying disease
Exclusion Criteria:
* previous bevacizumab treatment
* known eye disease, eye surgery or eye trauma in history
* myopia \>-2.0 dpt
* hyperopia \> +2.0 dpt.
* relevant media opacity of the lens
* acute heart disease, ischemic insult, proven coronary heart disease
* cardiac arrhythmia or vessel anomalies
* seizure disorder or episode in history
* migraine
* treatment with corticosteroids within 4 weeks before study inclusion
* intake of vasoactive drugs like AT-1 or glitazone
* pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00740168
Study Brief:
Protocol Section:
NCT00740168